Biochemical methods primarily employ antigen-antibody interactions by applying specific antibodies to tumour-specific biomarkers such as epithelial-cell adhesion molecule (EpCAM), prostate-specific antigen (PSA) and human epidermal growth factor receptor 2 (HER2) [42]. Here, ERBB2 is linked to neoplasm.